ondasdechoque.org
PT-BR

Patellar tendinopathy · Randomized trial · 2020

What does one shockwave session do to a sore kneecap tendon?

In this trial of 34 male basketball and volleyball players with jumper's knee, one focused shockwave session made the sore tendon less stiff straight away, more than a sham session. Squat pain eased a little in both groups; with shockwave, players whose tendon softened more tended to get more relief.

Explores how shockwave works
male basketball and volleyball players
34
session, measured right after
1
pulses at the strongest level each player could tolerate
1,500

Good to know: Small trial in young male athletes; everything was measured just before and right after the single session.

Zhang ZJ, Lee WC, Fu SN Journal of Sports Science & Medicine, 2020 · Read the paper ↗

How this study worked

Focused shockwave17 peopleSham17 peopleShockwaveSham
People were assigned by lot. One group had a sham: the same-looking treatment without the active waves. Each dot is one person.

Conceptual animation: a focused front converges, then spreads. Not to scale. Tap the field to send a pulse.

What happened

Knee pain during a single-leg squat

0–10 pain scale · just before and right after one session

BeforeRight after

Right after the session, squat pain eased a little in both groups: from about 5.1 to 4.5 with shockwave and from about 5.2 to 4.3 with sham.
Show the numbers
GroupPeopleBeforeRight after
Focused shockwave175.14.5
Sham175.24.3

The treatment

Focused shockwave

Focused, 1 session

Focused wavesMeet at a focal zone below the skin
Sessions
1
Pulses
1,500 per session
Strength
0.13–0.33mJ/mm² set at the most each player could tolerate · 4 per second
Numbing
Not mentioned
Device
Storz Minilith SL1

Compared with: A sham session: the same 1,500 pulses at a very low energy (below 0.08 mJ/mm²)

Settings are what each study used, not a prescription.

Who took part

34 male basketball and volleyball players (average age about 22) with jumper's knee, 17 in each group.

Focused shockwave17 people
Sham17 people

Side effects

Side effects were not reported. Treatment strength was set at the most pain each player could tolerate.

All the numbers and the full appraisal

Every reported result

FROM THE FULL PAPER

The results, in numbers.

Thirty-four male basketball/volleyball athletes with proximal patellar tendinopathy, randomized 17/17; mean age 22.2 years (SD 3.8).

Focused ESWT at maximum tolerable pain17randomized

Randomized group; Table 1 and Table 2 report n=17. The paper does not narrate any withdrawals.

Low-energy sham17randomized

Randomized group; Table 1 and Table 2 report n=17. Sham energy was below 0.08 mJ/mm².

Patellar tendon shear modulus1 reported outcome
01
Immediately before and after one session

Patellar tendon shear modulus

Supersonic Shearwave Imaging (SSI) kPa

Patellar tendon shear modulus · Immediately before and after one session · means
GroupnBaselineFollow-up
Focused ESWT at maximum tolerable pain1757.4 (SD 25.5)40.6 (SD 17.6)
Low-energy sham1747.7 (SD 17.1)41 (SD 12.7)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

REPORTED COMPARISON TESTp = 0.022

ESWT versus sham over time; estimate and CI not reported

sport-adjusted time×group interaction

Means are reported descriptively by group. The between-group test reported for this outcome is the sport-adjusted time×group interaction of the repeated-measures analysis (p=0.022); no between-group estimate or CI is given, and within-group change alone cannot establish comparative benefit.

Analysis details and source

Table reports mean ± SD. The sport-adjusted repeated-measures model found a time×group interaction p=0.022; its estimate and CI were not reported. Separate paired pre/post tests were p=0.001 for ESWT and p=0.06 for sham; these within-arm tests are distinct from the interaction. Pain rows have no reported p values.

Pain during standardized pressure1 reported outcome
02
Immediately before and after one session

Pain during standardized pressure

Visual Analogue Scale (VAS), pressure pain VAS points

BaselineFollow-up
Focused ESWT at maximum tolerable pain
6.2
Low-energy sham
5.7
010 VAS points
Pain during standardized pressure · Immediately before and after one session · means
GroupnBaselineFollow-up
Focused ESWT at maximum tolerable pain177 (SD 1.4)6.2 (SD 1.8)
Low-energy sham176.4 (SD 2)5.7 (SD 2.2)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

Means are reported descriptively by group. The paper does not provide a between-group estimate or inferential test for this outcome here; within-group change alone cannot establish comparative benefit.

Analysis details and source

Table reports mean ± SD. For shear modulus, the repeated-measures model adjusted for sport found a time×group interaction p=0.022; paired pre/post tests were p=0.001 for ESWT and p=0.06 for sham. Pain rows have no reported p values.

Pain during single-leg decline squat1 reported outcome
03
Immediately before and after one session

Pain during single-leg decline squat

Visual Analogue Scale (VAS), activity-related pain VAS points

BaselineFollow-up
Focused ESWT at maximum tolerable pain
4.5
Low-energy sham
4.3
010 VAS points
Pain during single-leg decline squat · Immediately before and after one session · means
GroupnBaselineFollow-up
Focused ESWT at maximum tolerable pain175.1 (SD 1.6)4.5 (SD 1.7)
Low-energy sham175.2 (SD 2)4.3 (SD 2)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

Means are reported descriptively by group. The paper does not provide a between-group estimate or inferential test for this outcome here; within-group change alone cannot establish comparative benefit.

Analysis details and source

Table reports mean ± SD. For shear modulus, the repeated-measures model adjusted for sport found a time×group interaction p=0.022; paired pre/post tests were p=0.001 for ESWT and p=0.06 for sham. Pain rows have no reported p values.

Change in tendon shear modulus correlated with change in decline-squat pain2 reported outcomes
04
Immediately before and after one session

Change in tendon shear modulus correlated with change in decline-squat pain

Supersonic Shearwave Imaging and VAS correlation coefficient

Spearman correlation (ρ)0.55Uncertainty interval unavailablep = 0.023

Association within the ESWT group only; not a treatment contrast.

17 participants in this estimate

Spearman correlation; no covariate adjustment reported.

A positive association was reported in the treated group; this does not show that the stiffness change caused pain relief.

Analysis details and source

The source reports correlations for the ESWT group and no pressure-pain correlation (p>0.05); exact pressure-pain ρ and p are not provided.

05
Immediately before and after one session

Percentage changes in shear modulus and decline-squat pain correlated

Supersonic Shearwave Imaging and VAS correlation coefficient

Spearman correlation (ρ)0.53Uncertainty interval unavailablep = 0.028

Association within the ESWT group only; not a treatment contrast.

17 participants in this estimate

Spearman correlation; no covariate adjustment reported.

A positive association was reported in the treated group; this does not show that the stiffness change caused pain relief.

Analysis details and source

The source reports correlations for the ESWT group and no pressure-pain correlation (p>0.05); exact pressure-pain ρ and p are not provided.

How treatment was delivered
Modality/device

Focused ESWT using a Storz Minilith SL1 lithotripter.

Active dose

One session, 1,500 impulses at 4 Hz at maximal tolerable pain; first 500 impulses used to establish tolerance. EFD ranged 0.13–0.33 mJ/mm²; 15/17 received <0.25 mJ/mm².

Target/technique

Most painful proximal patellar tendon site, palpated and marked; contact gel used. For bilateral symptoms, the side more painful in the prior seven days was treated.

Sham

1,500 impulses at 4 Hz below 0.08 mJ/mm².

Frequency/pressure/anesthesia/cointervention

Frequency reported as 4 Hz; bar pressure, anesthesia and cointerventions not reported.

HARMS & TOLERABILITY

No structured harms results or adverse-event counts were reported in the article. The treatment was delivered at maximal tolerable pain; absence of reporting is not zero risk.

LIMITS OF THE ANALYSIS

Immediate-only outcome assessment and small sample (17 per randomized group); no long-term patient-important outcomes.

The article’s active-arm percentage reduction differs between the Results (26.7%) and Discussion (29.5%).

The Table 2 row is labeled mean difference (95% CI) but presents values with ± and the table says means±SD; they are not treated as CIs.

No between-group effect estimate or CI is given for the stiffness interaction; separate within-group p values do not establish superiority.

Only male jumping-sport athletes were included, and assessment was immediate, limiting generalizability.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • Immediate-only outcome assessment and small sample (17 per randomized group); no long-term patient-important outcomes.
  • The article’s active-arm percentage reduction differs between the Results (26.7%) and Discussion (29.5%).
  • The Table 2 row is labeled mean difference (95% CI) but presents values with ± and the table says means±SD; they are not treated as CIs.
  • No between-group effect estimate or CI is given for the stiffness interaction; separate within-group p values do not establish superiority.
  • Only male jumping-sport athletes were included, and assessment was immediate, limiting generalizability.
Research review

Source-linked critical reading

Randomized trial with acute mechanistic outcomes

Reading depthMaterial consulted
Technical source record

Complete full-article HTML read, all eight sections, both tables and four figure captions. No supplementary material was supplied.

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Design

Thirty-four participants were randomized to ESWT or sham (17 per group), with measurements immediately before and after one session. Patients were blinded; the therapist delivering treatment was not, while a separate assessor/operator unaware of allocation measured tendon stiffness.

Participants

Male basketball and volleyball athletes aged 18–35 with at least three months of symptoms, recent-week pain ≥3/10, VISA-P <80, and proximal tendon tenderness/imaging findings were eligible. Mean age was 22.2 (SD 3.8); the groups were similar on baseline characteristics. Forty-three were recruited; seven with VISA-P >80 and two with VAS <3 were excluded, leaving 34.

Intervention

One focused session used a Storz Minilith SL1 lithotripter at the most painful proximal tendon site: 1,500 impulses at 4 Hz, maximal tolerable pain intensity; the first 500 impulses established tolerance. ESWT energy flux density ranged 0.13–0.33 mJ/mm²; 15/17 received <0.25, with 8 at 0.13, 6 at 0.17, and 1 at 0.22 mJ/mm².

Comparator

The sham group received 1,500 impulses at 4 Hz below 0.08 mJ/mm². Patients were not told which intervention they received; the article says the machine noise and potential pain were explained. The target was the more painful side if symptoms were bilateral.

Outcomes and timing

Primary measure was proximal tendon shear modulus by Supersonic Shearwave Imaging before and immediately after treatment. Secondary pain measures were VAS during standardized 10-lb pressure over the most tender region and during single-leg squat on a 25° decline board. No longer-term outcomes were collected.

Between-group findings

Shear modulus fell from 57.4 (SD 25.5) to 40.6 (17.6) kPa in ESWT (n=17), and from 47.7 (17.1) to 41.0 (12.7) in sham (n=17). The sport-adjusted time×group interaction was p=0.022; paired tests were p=0.001 and p=0.06, respectively. Results call the active percentage reduction 26.7% (SD 19.1), while Discussion says 29.5%; the table’s absolute mean differences are 16.8 and 6.7 kPa. The interaction estimate/CI is not reported. Pain means also declined in both arms, but Table 2 provides no inferential between-group pain test. In ESWT participants, stiffness change correlated with decline-squat pain change (ρ=0.55, p=0.023; percentage changes ρ=0.53, p=0.028), but not pressure pain (p>0.05). Correlation is not causal mediation.

Harms and tolerability

The article does not provide a structured adverse-event assessment or event counts. Treatment was delivered at the participant’s maximal tolerable pain. Absence of harm reporting should not be interpreted as zero harms.

Limitations and uncertainty

The primary result is immediate and based on only 17 participants per arm; no between-group interaction estimate or confidence interval is given. The paper reports significant within-ESWT change and nonsignificant within-sham change, but those separate p values do not by themselves prove a treatment difference; the time×group interaction is the relevant comparison. The active-arm percentage reduction differs between Results (26.7%) and Discussion (29.5%). Table 2 labels mean difference (95% CI) but prints mean±SD values, so these are not interpreted as confidence intervals. Pain group changes have no reported between-group test. Only men in jumping sports were included, and no follow-up beyond the immediate assessment occurred.

Applicability

This acute mechanistic study applies to young male basketball/volleyball athletes with proximal patellar tendinopathy. It cannot establish durable symptom relief, functional improvement, prevention of recurrence, or effectiveness in women and other sports. Shear modulus is a stiffness index, not a direct patient-important outcome.

What stronger research should do

Future trials should report a prespecified between-group treatment effect with confidence intervals, clarify the absolute and percentage change discrepancy, include clinically meaningful pain and function outcomes over months, standardize dose reporting, and prospectively collect adverse events. Larger, sex-inclusive samples and sport-stratified analyses would improve generalizability.

THE ORIGINAL SOURCE

Read the original article.

One Session of Extracorporeal Shockwave Therapy-Induced Modulation on Tendon Shear Modulus is Associated with Reduction in Pain.

Zhang ZJ, Lee WC, Fu SN. · Journal of sports science & medicine · 2020

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →